constructive biology limited
constructive biology limited Company Information
Company Number
13758641
Next Accounts
Aug 2025
Industry
Research and experimental development on biotechnology
Shareholders
paladin cyber spv ii llc series 40
omx ventures fund i llc
View AllGroup Structure
View All
Contact
Registered Address
27 old gloucester street, london, WC1N 3AX
Website
-constructive biology limited Estimated Valuation
Pomanda estimates the enterprise value of CONSTRUCTIVE BIOLOGY LIMITED at £1.5m based on a Turnover of £1m and 1.5x industry multiple (adjusted for size and gross margin).
constructive biology limited Estimated Valuation
Pomanda estimates the enterprise value of CONSTRUCTIVE BIOLOGY LIMITED at £0 based on an EBITDA of £-2.7m and a 5.36x industry multiple (adjusted for size and gross margin).
constructive biology limited Estimated Valuation
Pomanda estimates the enterprise value of CONSTRUCTIVE BIOLOGY LIMITED at £16.5m based on Net Assets of £9m and 1.84x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Constructive Biology Limited Overview
Constructive Biology Limited is a live company located in london, WC1N 3AX with a Companies House number of 13758641. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in November 2021, it's largest shareholder is paladin cyber spv ii llc series 40 with a 15% stake. Constructive Biology Limited is a startup, small sized company, Pomanda has estimated its turnover at £1m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Constructive Biology Limited Health Check
Pomanda's financial health check has awarded Constructive Biology Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £1m, make it smaller than the average company (£3.4m)
- Constructive Biology Limited
£3.4m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Constructive Biology Limited
- - Industry AVG
Production
with a gross margin of 53.7%, this company has a comparable cost of product (53.7%)
- Constructive Biology Limited
53.7% - Industry AVG
Profitability
an operating margin of -281.8% make it less profitable than the average company (-1.1%)
- Constructive Biology Limited
-1.1% - Industry AVG
Employees
with 15 employees, this is below the industry average (46)
15 - Constructive Biology Limited
46 - Industry AVG
Pay Structure
on an average salary of £75.9k, the company has an equivalent pay structure (£75.9k)
- Constructive Biology Limited
£75.9k - Industry AVG
Efficiency
resulting in sales per employee of £67.4k, this is less efficient (£130.1k)
- Constructive Biology Limited
£130.1k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (54 days)
- Constructive Biology Limited
54 days - Industry AVG
Creditor Days
its suppliers are paid after 237 days, this is slower than average (60 days)
- Constructive Biology Limited
60 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Constructive Biology Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1007 weeks, this is more cash available to meet short term requirements (30 weeks)
1007 weeks - Constructive Biology Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 4.5%, this is a lower level of debt than the average (54.6%)
4.5% - Constructive Biology Limited
54.6% - Industry AVG
CONSTRUCTIVE BIOLOGY LIMITED financials
Constructive Biology Limited's latest turnover from November 2023 is estimated at £1 million and the company has net assets of £9 million. According to their latest financial statements, Constructive Biology Limited has 15 employees and maintains cash reserves of £8.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2023 | Nov 2022 | |
|---|---|---|
| Turnover | ||
| Other Income Or Grants | ||
| Cost Of Sales | ||
| Gross Profit | ||
| Admin Expenses | ||
| Operating Profit | ||
| Interest Payable | ||
| Interest Receivable | ||
| Pre-Tax Profit | ||
| Tax | ||
| Profit After Tax | ||
| Dividends Paid | ||
| Retained Profit | ||
| Employee Costs | ||
| Number Of Employees | 15 | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2023 | Nov 2022 | |
|---|---|---|
| Tangible Assets | 561,213 | 519,644 |
| Intangible Assets | 0 | 0 |
| Investments & Other | 54,544 | 54,544 |
| Debtors (Due After 1 year) | 0 | 0 |
| Total Fixed Assets | 615,757 | 574,188 |
| Stock & work in progress | 0 | 0 |
| Trade Debtors | 2,400 | 0 |
| Group Debtors | 0 | 0 |
| Misc Debtors | 635,317 | 441,817 |
| Cash | 8,134,471 | 2,232,129 |
| misc current assets | 0 | 0 |
| total current assets | 8,772,188 | 2,673,946 |
| total assets | 9,387,945 | 3,248,134 |
| Bank overdraft | 0 | 0 |
| Bank loan | 0 | 0 |
| Trade Creditors | 304,662 | 84,334 |
| Group/Directors Accounts | 0 | 0 |
| other short term finances | 0 | 0 |
| hp & lease commitments | 0 | 0 |
| other current liabilities | 115,049 | 20,290 |
| total current liabilities | 419,711 | 104,624 |
| loans | 0 | 0 |
| hp & lease commitments | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 |
| other liabilities | 0 | 0 |
| provisions | 0 | 0 |
| total long term liabilities | 0 | 0 |
| total liabilities | 419,711 | 104,624 |
| net assets | 8,968,234 | 3,143,510 |
| total shareholders funds | 8,968,234 | 3,143,510 |
| Nov 2023 | Nov 2022 | |
|---|---|---|
| Operating Activities | ||
| Operating Profit | ||
| Depreciation | 114,026 | 44,801 |
| Amortisation | 0 | 0 |
| Tax | ||
| Stock | 0 | 0 |
| Debtors | 195,900 | 441,817 |
| Creditors | 220,328 | 84,334 |
| Accruals and Deferred Income | 94,759 | 20,290 |
| Deferred Taxes & Provisions | 0 | 0 |
| Cash flow from operations | ||
| Investing Activities | ||
| capital expenditure | ||
| Change in Investments | 0 | 54,544 |
| cash flow from investments | ||
| Financing Activities | ||
| Bank loans | 0 | 0 |
| Group/Directors Accounts | 0 | 0 |
| Other Short Term Loans | 0 | 0 |
| Long term loans | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 |
| other long term liabilities | 0 | 0 |
| share issue | ||
| interest | ||
| cash flow from financing | ||
| cash and cash equivalents | ||
| cash | 5,902,342 | 2,232,129 |
| overdraft | 0 | 0 |
| change in cash | 5,902,342 | 2,232,129 |
constructive biology limited Credit Report and Business Information
Constructive Biology Limited Competitor Analysis
Perform a competitor analysis for constructive biology limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in WC1N area or any other competitors across 12 key performance metrics.
constructive biology limited Ownership
CONSTRUCTIVE BIOLOGY LIMITED group structure
Constructive Biology Limited has no subsidiary companies.
Ultimate parent company
CONSTRUCTIVE BIOLOGY LIMITED
13758641
constructive biology limited directors
Constructive Biology Limited currently has 6 directors. The longest serving directors include Dr Jason Chin (Nov 2021) and Mr Paul Conley (May 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Jason Chin | United Kingdom | 51 years | Nov 2021 | - | Director |
| Mr Paul Conley | United Kingdom | 56 years | May 2022 | - | Director |
| Dr Aleksandra Wlodek | United Kingdom | 39 years | Jul 2022 | - | Director |
| Mr Rahul Dhanda | United Kingdom | 51 years | Apr 2023 | - | Director |
| Mr Shyam Kamadolli | United Kingdom | 56 years | Sep 2024 | - | Director |
| Sir Gregory Winter | England | 73 years | Sep 2024 | - | Director |
P&L
November 2023turnover
1m
+185%
operating profit
-2.8m
0%
gross margin
53.7%
+2.55%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
9m
+1.85%
total assets
9.4m
+1.89%
cash
8.1m
+2.64%
net assets
Total assets minus all liabilities
Similar Companies
constructive biology limited company details
company number
13758641
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
November 2021
age
4
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
November 2023
previous names
constructive genomics limited (August 2022)
accountant
-
auditor
-
address
27 old gloucester street, london, WC1N 3AX
Bank
-
Legal Advisor
-
constructive biology limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to constructive biology limited.
constructive biology limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CONSTRUCTIVE BIOLOGY LIMITED. This can take several minutes, an email will notify you when this has completed.
constructive biology limited Companies House Filings - See Documents
| date | description | view/download |
|---|
